ABCELLERA BIOLOGICS INC (ABCL) Stock Balance Sheet
NASDAQ:ABCL • CA00288U1066
Current stock price
3.43 USD
+0.13 (+3.94%)
At close:
3.445 USD
+0.01 (+0.44%)
Pre-Market:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 128.51M | 156.32M | 133.32M | 386.50M | 476.10M | |||
| Marketable Securities | 405.31M | 469.29M | 627.26M | 500.00M | 246.80M | |||
| Receivables | 153.40M | 92.13M | 64.38M | 103.40M | 174.90M | |||
| Inventories | 6.34M | N/A | 1.11M | 1.50M | 1.70M | |||
| Other Current Assets | 34.67M | 33.63M | 45.91M | 34.10M | 30.30M | |||
| Total Current Assets | 728.23M | 751.37M | 871.99M | 1.03B | 929.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 428.00M | 340.43M | 287.70M | 217.30M | 111.60M | |||
| Investments And Advances | 95.08M | 114.60M | 98.24M | 72.50M | 50.30M | |||
| Goodwill | 47.81M | 47.81M | 47.81M | 47.80M | 47.80M | |||
| Intangibles | 38.38M | 42.11M | 120.42M | 131.50M | 148.40M | |||
| Other Non-Current Assets | 19.45M | 64.24M | 61.94M | 46.30M | 30.60M | |||
| Total Non-Current Assets | 628.72M | 609.18M | 616.11M | 515.40M | 388.80M | |||
| TOTAL ASSETS | 1.36B | 1.36B | 1.49B | 1.54B | 1.32B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 16.57M | 13.00M | 13.87M | 12.00M | 3.70M | |||
| Accounts Payable | 25.23M | 34.35M | 25.51M | 14.80M | 14.90M | |||
| Other Current Liabilities | 22.51M | 29.27M | 79.64M | 91.50M | 102.10M | |||
| Total Current Liabilities | 64.31M | 76.61M | 119.01M | 118.30M | 120.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 9.12M | 10.05M | 30.61M | 33.20M | 37.40M | |||
| Other Non-Current Liabilities | 316.62M | 217.81M | 186.15M | 156.10M | 134.80M | |||
| Total Non-Current Liabilities | 325.74M | 227.86M | 216.76M | 189.30M | 172.10M | |||
| TOTAL LIABILITIES | 390.05M | 304.47M | 335.78M | 307.60M | 292.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -29.48M | 116.93M | 279.79M | 426.20M | 267.70M | |||
| Additional Paid In Capital | 198.28M | 166.36M | 121.05M | 74.10M | 35.40M | |||
| Common Shares | 802.34M | 777.17M | 753.20M | 734.40M | 722.40M | |||
| Other Shareholders' Equity | -4.23M | -4.38M | -1.72M | -1.40M | 300.00K | |||
| Shares Outstanding | 300.60M | 295.76M | 290.82M | 286.90M | 283.30M | |||
| Tangible Book Value per Share | 2.93 | 3.27 | 3.38 | 3.67 | 2.93 | |||
| Total Shareholders' Equity | 966.90M | 1.06B | 1.15B | 1.23B | 1.03B | |||
| TOTAL LIABILITIES AND EQUITY | 1.36B | 1.36B | 1.49B | 1.54B | 1.32B | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 11.32 | 9.81 | 7.33 | 8.67 | 7.70 | |||
| Return On Assets (ROA) | -10.79% | -11.97% | -9.84% | 10.29% | 11.64% | |||
| Return On Equity (ROE) | -15.14% | -15.42% | -12.70% | 12.85% | 14.97% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | 12.02% | 13.48% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | 31.90% | 33.99% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | N/A | 47.94% | 57.92% | |||
All data in USD , ROIC based on taxRate of 0.21